Dual Metronomic Chemotherapy with Nab-Paclitaxel and Topotecan Has Potent Antiangiogenic Activity in Ovarian Cancer

Overview of attention for article published in Molecular Cancer Therapeutics, December 2015

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (54th percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 3,951 followers.

"Metronomic Nab-Paclitaxel and Topotecan Inhibit Angiogenesis" https://t.co/WzLWhiNOly #journals #feedly .

Dual metronomic chemotherapy with nab-paclitaxel and topotecan has potent anti-angiogenic activity in ovarian… https://t.co/NB6VwUHNg1

Dual metronomic chemo w/ nab-paclitaxel & topotecan has potent anti-angiogenic activity in ovarian cancer. https://t.co/UFMZ265B3H

Dual metronomic chemotherapy with nab-paclitaxel and topotecan has potent anti-angiogenic activity in ovarian… https://t.co/4bm0M7TQTw

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.